THURSDAY, SEPTEMBER 29, 2016

Researchers develop test to detect virtually any virus

A new test that can detect virtually any virus that could infect any human or animal has been developed at Washington University School of Medicine in St. Louis. Read More »

TB vaccine candidate trial begins in South Africa

The Infectious Disease Research Institute (IDRI) and Wellcome Trust announced that they have started the Phase 2a trial of a tuberculosis (TB) vaccine candidate in South Africa. Read More »

Generex signs letter of intent with Hema Diagnostic Systems

Generex Biotechnology Corp. has signed a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS), a Florida-based firm that develops and produces proprietary infectious disease detection technologies. Read More »

University of Tokyo develops statistical method for estimating death risks during disease outbreaks

Researchers at the University of Tokyo have developed a real-time statistical method to estimate risk of death as well as to identify risk factors of death during an infectious disease outbreak. Read More »

Wales reports more children than ever receiving MMR vaccine

Statistics published Tuesday by Welsh government officials  show that more children in Wales have received the measles, mumps and rubella (MMR) vaccine than ever before. The figures indicate 93 percent of Welsh children who had reached their fifth birthdays as of March 31 had received the recommended two doses of the vaccine. Read More »

WHO issues treat-all recommendation for HIV

The World Health Organization (WHO) released a treat-all recommendation on Wednesday for those affected by the human immunodeficiency virus (HIV) that eliminates all limitations on the use of, and eligibility for, antiretroviral therapy.  Read More »

WHO reports six additional MERS cases in Saudi Arabia

The World Health Organization (WHO) reported on Wednesday that six cases of the Middle East respiratory syndrome (MERS) coronavirus have been reported in Saudi Arabia between Sept. 20 and 26. Read More »

New drug may present alternative malaria treatment for pregnant women

Dihydroartemisinin-piperaquine found to be effective as a preventative treatment for malaria. Read More »

Researchers identify protein vulnerability in HIV virus

HIV research has expanded tremendously in the past 30 years, and the biology of the virus is almost completely understood by researchers, but the infectious process of the virus still baffles researchers to an extent. Read More »

Study: Type 1 diabetes may transform intestinal lining

Up to 80 percent of patients with type 1 diabetes develop diabetic enteropathy, a set of gastrointestinal symptoms that include irritable bowel syndrome, abdominal distension and fecal incontinence, and a recent study suggests that the disease may actual alter the intestines' structure. Read More »

WHO's new HIV guidelines call for antiretroviral therapy for all patients

New World Health Organization (WHO) guidelines recommend that antiretroviral therapy (ART) be administered to any patient with HIV -- even those whose immune systems have not yet been compromised (based on the CD4 cell count in the bloodstream). Read More »

Doctors Without Borders praises WHO for new HIV antiretroviral 'treat all' stance

The World Health Organization recently established new guidelines recommending that all patients testing positive for HIV be offered immediate antiretroviral treatment, a move that was cheered by international medical humanitarian organization Médecins Sans Frontières/Doctors Without Borders (MSF). Read More »

Despite high TB rates in Africa, residents often excluded from drug trials

Although tuberculosis is the leading cause of death in HIV patients in Africa, these patients are largely excluded from the early stages of testing and development of anti-tuberculosis drugs. These findings were revealed at the recent European Respiratory Society's International Congress 2015 in Amsterdam. Read More »

Alere redoubles efforts with Organization of African First Ladies Against HIV/AIDS

Alere said this week that it is redoubling its commitment to support the Organization of African First Ladies Against HIV/AIDS (OAFLA). Alere, a global leader in rapid diagnostics, aims to help reduce the impact of HIV/AIDS in Africa, specifically mother-to-child transmission. Read More »

WHO: 10 more MERS cases reported in Saudi Arabia, Jordan

The Centre for Health Protection (CHP) recently provided an update on the Middle East Respiratory Syndrome (MERS) situation in Saudi Arabia and Jordan. As of Friday, 10 additional cases of MERS have been reported to the World Health Organization (WHO), with six of those patients being in stable condition, two remaining asymptomatic and two dying from the viral respiratory illness. Read More »

PRA Health, Alliance for Multispecialty Research team up on vaccines

PRA Health Sciences (PRA) and the Alliance for Multispecialty Research (AMR) have teamed up to get new vaccines to market more quickly. "This is an ideal collaboration," Frank Hijek, PRA's senior vice president for strategic drug development, said. Read More »

Hong Kong agency advises tourist vigilance in MERS-affected Mideast nations

The Center for Health Protection (CHP) of the Department of Health for the government of Hong Kong is advising the public on Friday to pay attention to any respiratory problems that develop while traveling in Saudi Arabia and other Mideast nations.The CHP, along with the World Health Organization (WHO), is monitoring several cases of Middle East Respiratory Syndrome (MERS) in Saudi Arabia in the latest outbreak. Read More »

NewLink Genetics awarded federal contract to work on Ebola test vaccine

The Department of Defense’s Defense Threat Reduction Agency (DTRA) has awarded a NewLink Genetics subsidiary with an $8.1 million base contract, with the option of a further $5.2 million, to work on development of the rVSV-ZEBOV (Ebola) vaccine candidate, NewLink Genetics said recently. Read More »

HHS unit sponsoring development of drug for severe flu cases

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) is sponsoring a drug being developed to treat patients hospitalized with severe cases of influenza. the Biomedical Advanced Research and Development Authority (BARDA) said this week. Read More »

Translucent fish larvae allow scientists to view progression of meningitis infection

Researchers from Duke University Medical Center recently developed a new method to witness how cryptococcal meningitis infections take over the brain, a process that kills roughly 600,000 people each year, by watching the progression in infected zebra fish larvae, whose bodies are translucent. Read More »